A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Trial details
- Registry ID
- NCT07812090
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular EdemaNCT07812090 | BIOA | Phase 2 | Recruiting | 2027-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |